Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Cancer Research
|
December 9, 2020
Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors
Soon Young Park, Sandeep Mittal, Jianwen Dong, et al.
Cancer
|
March 15, 2021
Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis
Chonnipa Nantavithya, Arnold C Paulino, Kaiping Liao, et al.
The Journal of Biological Chemistry
|
December 17, 2013
Degradation of activated K-Ras orthologue via K-Ras-specific lysine residues is required for cytokinesis
Kazutaka Sumita, Hirofumi Yoshino, Mika Sasaki, et al.
Plos One
|
August 8, 2019
Identification of lysine methylation in the core GTPase domain by GoMADScan
Hirofumi Yoshino, Guowei Yin, Risa Kawaguchi, et al.
Plos One
|
October 23, 2019
Correction: Identification of lysine methylation in the core GTPase domain by GoMADScan
Hirofumi Yoshino, Guowei Yin, Risa Kawaguchi, et al.
Molecular Cell
|
January 18, 2016
The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis
Kazutaka Sumita, Yu-Hua Lo, Koh Takeuchi, et al.
Research Square
|
June 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types
David Raleigh, S John Liu, Nazanin Majd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Acta Neuropathologica
|
May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
Andrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
Nature Cell Biology
|
August 3, 2019
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
Satoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Cancer Research
|
December 9, 2020
Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors
Soon Young Park, Sandeep Mittal, Jianwen Dong, et al.
Cancer
|
March 15, 2021
Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis
Chonnipa Nantavithya, Arnold C Paulino, Kaiping Liao, et al.
The Journal of Biological Chemistry
|
December 17, 2013
Degradation of activated K-Ras orthologue via K-Ras-specific lysine residues is required for cytokinesis
Kazutaka Sumita, Hirofumi Yoshino, Mika Sasaki, et al.
Plos One
|
August 8, 2019
Identification of lysine methylation in the core GTPase domain by GoMADScan
Hirofumi Yoshino, Guowei Yin, Risa Kawaguchi, et al.
Plos One
|
October 23, 2019
Correction: Identification of lysine methylation in the core GTPase domain by GoMADScan
Hirofumi Yoshino, Guowei Yin, Risa Kawaguchi, et al.
Molecular Cell
|
January 18, 2016
The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis
Kazutaka Sumita, Yu-Hua Lo, Koh Takeuchi, et al.
Research Square
|
June 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types
David Raleigh, S John Liu, Nazanin Majd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Acta Neuropathologica
|
May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
Andrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
Nature Cell Biology
|
August 3, 2019
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
Satoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt, et al.
Page
of 2